Research and Clinical Trials

Our Mission Includes Research

Goodman Campbell physicians have a dedicated interest in clinical research related to neurologic conditions. Our physician specialists and research team actively pursue and are involved in a variety of clinical trials. From infants to adults, we are researching areas including the brain, spine, stroke and interventional pain management. Our research nurses and staff are experts in their areas of study and in the clinical trials we are conducting. Please explore our research options below and contact us at 317-396-1300 with any questions.

Current Clinical Trials

Differential-Target Multiplex Low Energy Spinal Cord Stimulation (DTM-LE SCS) Study
Investigators: Todd Schmidt, MD
Sponsor: Medtronic
Focus: Patients with chronic pain undergoing evaluation for placement of an implantable Medtronic Intellis AdaptiveStim Neurostimulation System are eligible for consideration in this study. The study seeks to evaluate programming parameters within the neurostimulation system.
ClinicalTrials.gov Identifier: NCT04601454

Long-Term Real-World Outcomes Study on Patients Implanted with a Neurostimulator (REALITY)
Investigator: Derron Wilson, MD
Sponsor: Abbott Medical Devices
Focus: Patients scheduled to receive an implantable Abbott neurostimulation system for chronic pain are eligible for consideration in this study. The goal of the study is to collect safety and effectiveness data on various populations implanted with the systems.
ClinicalTrials.gov Identifier: NCT03876054

Dorsal spInal cord STImulatioN vs mediCal management for the Treatment of low back pain (DISTINCT)
Investigator: Derron Wilson, MD
Sponsor: Abbott Medical Devices
Focus: The purpose of this prospective, multi-center, randomized, controlled, post market study
is to evaluate the effectiveness of SCS stimulation compared with conventional medical
management (CMM) in the treatment of chronic low back pain (CLBP) for patients who
have not undergone and are not candidates for lumbar spine surgery.

Study to Demonstrate the Value of Paresthesia-Free Fast-Acting Subperception (FAST) and Other SCS Therapies Using WaveWriter Spinal Cord Stimulator Systems in the Treatment of Chronic Pain
Investigator: Derron Wilson, MD
Sponsor: Boston Scientific
Focus: A study to evaluate the effectiveness of the systems in the management of chronic low back and/or leg pain, including one-sided or both sides associated with the following: failed back surgery syndrome, Complex Regional Pain Syndrome (CRPS) Types I and II, low back pain and leg pain.

SOFia Aspiration System as First Line Technique (SOFAST)
Investigators: Daniel Sahlein, MD; Krishna Amuluru, MD; Andrew DeNardo, MD; John Scott, MD
Sponsor: Microvention
Focus: This is an observational study involving patients undergoing thrombectomy following acute ischemic stroke in the anterior circulation. The goal of the study is to assess functional, imaging and safety outcomes of the SOFIA aspiration catheter.

Endovascular Treatment of Wide-Neck Aneurysms, and Evaluation of Safety and Effectiveness of Stryker Surpass Evolve Flow Diverter System
Investigators: Daniel Sahlein, MD; Krishna Amuluru, MD; Andrew DeNardo, MD; John Scott, MD
Sponsor: Stryker
Focus: This study will collect data on the use of the Surpass Evolve Flow Diverter to determine its safety and efficacy for use in wide-neck unruptured intracranial aneurysms.

Brain Oxygen Optimization in Severe Traumatic Brain Injury- Phase 3 (BOOST-3)
Investigators: Richard Rodgers, MD; Charles Kulwin, MD; Eric Horn PhD, MD
Sponsor: The National Institute of Neurological Disorders and Stroke (NINDS)
Focus: A randomized clinical trial to determine the comparative effectiveness of two strategies for monitoring and treating patients with traumatic brain injury (TBI) in the intensive care unit (ICU). The study will determine the safety and efficacy of a strategy guided by treatment goals based on both intracranial pressure (ICP) and brain tissue oxygen (PbtO2) as compared to a strategy guided by treatment goals based on ICP monitoring alone. Both of these alternative strategies are used in standard care. The results of this study will help doctors discover if one of these methods is more safe and effective.
ClinicalTrials.gov Identifier: NCT03754114

Clinical Evaluation of the i-STAT TBI Test – enrollment to begin mid-summer 2021
Investigators: Richard Rodgers, MD; Charles Kulwin, MD
Sponsor: Abbott
Focus: The purpose of this study is to evaluate the clinical performance of the i-STAT TBI test for the proposed intended use; to assist in determining the need for a CT scan in patients presenting with suspected mild traumatic brain injury who are 18 years of age or older. The secondary objective of this study is the collection of additional data and specimens from all study subjects that may support other purposes related to the understanding of TBI.
ClinicalTrials.gov Identifier: NCT04171960

ENRICH: Early Minimally-invasive Removal of Intracerebral Hemorrhage (ICH)
Investigators: Charles Kulwin, MD; Richard B. Rodgers, MD
Sponsor: Nico Corporation
Focus: Patients in the hospital due to spontaneous intracerebral hemorrhage able to be enrolled within 24 hours of symptom onset may be considered for participation in this trial. This is an interventional trial comparing groups receiving medical management or early surgical hematoma evacuation.
ClinicalTrials.gov Identifier: NCT02880878

Neuromonitoring for Percutaneous Balloon Rhizotomy for Trigeminal Neuralgia
Investigators: Charles Kulwin, MD; Troy Payner, MD
Sponsor: The Neurosurgery Foundation at Goodman Campbell
Focus: This investigator-initiated pilot study explores the use of neuromonitoring during balloon rhizotomy procedures for trigeminal neuralgia. The goal is to determine if neuromonitoring is useful with these procedures and if it can be used to determine the duration of nerve compression needed for individual patients.

Electrophysiological Analysis of Epileptogenic Tissue
Investigator: Jodi Smith, MD
Sponsor: The Neurosurgery Foundation at Goodman Campbell
Focus: Translational research study utilizing tissue from seizure surgeries to test medications that may in the future be potential treatments for epilepsy. Pediatric patients undergoing surgical resection for epilepsy may be eligible to participate by donating the tissue removed during their epilepsy surgery.

Hydrocephalus Clinical Research Network (HCRN) Registry
Investigator: Jodi Smith, MD
Sponsor: Unfunded
Focus: This is a multi-center research network seeking to gather information regarding pediatric hydrocephalus and treatments. Pediatric patients undergoing treatment for hydrocephalus may be included.

A Pivotal Study of the Premia Spine TOPS System
Investigators: Eric Potts, MD; John DePowell, MD; Eric Horn, MD; Saad Khairi, MD; Charles Kulwin, MD; Jean-Pierre Mobasser, MD; Shannon McCanna, MD; Richard B. Rodgers, MD
Sponsor: Premia Spine
Focus: The TOPS System was designed as an alternative to fusion and is a motion preserving posterior spine implant designed to provide dynamic stabilization to a single lumbar spine segment following decompression surgery. The purpose of the trial is to assess whether the TOPS system is more effective than transforaminal lumbar interbody fusion (TLIF) when utilized in a specific population of patients undergoing single level lumbar fusion.
ClinicalTrials.gov Identifier: NCT03012776

Goodman Campbell Brain and Spine physicians publish research results from clinical trials and independent clinical investigations in peer-reviewed biomedical journals. Abstracts, full-text articles and videos can be accessed through the following online resources:

Request an appointment online and we will guide you through the next steps.